KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Change in Receivables (2018 - 2025)

ClearPoint Neuro's Change in Receivables history spans 13 years, with the latest figure at -$260000.0 for Q3 2025.

  • For Q3 2025, Change in Receivables fell 164.84% year-over-year to -$260000.0; the TTM value through Sep 2025 reached $552000.0, down 57.51%, while the annual FY2024 figure was $1.2 million, 33.15% down from the prior year.
  • Change in Receivables for Q3 2025 was -$260000.0 at ClearPoint Neuro, down from $609000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.2 million in Q2 2022 and bottomed at -$846000.0 in Q1 2024.
  • The 5-year median for Change in Receivables is $184000.0 (2023), against an average of $178000.0.
  • The largest annual shift saw Change in Receivables skyrocketed 489.47% in 2023 before it plummeted 559.78% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$190000.0 in 2021, then crashed by 305.79% to -$771000.0 in 2022, then skyrocketed by 248.12% to $1.1 million in 2023, then fell by 8.14% to $1.0 million in 2024, then tumbled by 124.79% to -$260000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Change in Receivables are -$260000.0 (Q3 2025), $609000.0 (Q2 2025), and -$846000.0 (Q1 2025).